{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:41:15Z","timestamp":1793400075504,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Planning Project of Li Shui City","award":["2023SJZC091"],"award-info":[{"award-number":["2023SJZC091"]}]},{"name":"Zhejiang Provincial Natural Science Foundation Joint Project","award":["LLSSY24H160001"],"award-info":[{"award-number":["LLSSY24H160001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04388-x","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T01:32:28Z","timestamp":1756258348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differential gene expression and immune profiling in Parkinson\u2019s disease: unveiling potential candidate biomarkers"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiuping","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"2","key":"4388_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","volume":"36","author":"T Li","year":"2020","unstructured":"Li T, Le W. Biomarkers for Parkinson\u2019s disease: how good are they?? Neurosci Bull. 2020;36(2):183\u201394. https:\/\/doi.org\/10.1007\/s12264-019-00433-1.","journal-title":"Neurosci Bull"},{"key":"4388_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060912","author":"A Polissidis","year":"2020","unstructured":"Polissidis A, Petropoulou-Vathi L, Nakos-Bimpos M, Rideout HJ. The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10060912.","journal-title":"Biomolecules"},{"key":"4388_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914582","volume":"24","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Andronie-Cioara FL, Nistor-Cseppento DC, Pascalau N, Rus M, Vasca E, et al. The involvement of neuroinflammation in the onset and progression of parkinson\u2019s disease. Int J Mol Sci. 2023;24: 19. https:\/\/doi.org\/10.3390\/ijms241914582.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4388_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00281-022-00947-3","volume":"44","author":"B Zhu","year":"2022","unstructured":"Zhu B, Yin D, Zhao H, Zhang L. The immunology of Parkinson\u2019s disease. Semin Immunopathol. 2022;44(5):659\u201372. https:\/\/doi.org\/10.1007\/s00281-022-00947-3.","journal-title":"Semin Immunopathol"},{"key":"4388_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00527-8","author":"X Guo","year":"2023","unstructured":"Guo X, Hu W, Gao Z, Fan Y, Wu Q, Li W. Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson\u2019s disease based on integrative analysis. NPJ Parkinsons Dis. 2023. https:\/\/doi.org\/10.1038\/s41531-023-00527-8.","journal-title":"NPJ Parkinsons Dis"},{"key":"4388_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38 8","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia Nigra of parkinson\u2019s and alzheimer\u2019s disease brains. Neurology. 1988;38 8:1285\u201391. https:\/\/doi.org\/10.1212\/wnl.38.8.1285.","journal-title":"Neurology"},{"issue":"2","key":"4388_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11 C](R)-PK11195 PET in idiopathic parkinson\u2019s disease. Neurobiol Dis. 2006;21(2):404\u201312. https:\/\/doi.org\/10.1016\/j.nbd.2005.08.002.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"4388_CR8","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bov\u00e9 J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of parkinson\u2019s disease. Brain. 2020;143(12):3717\u201333. https:\/\/doi.org\/10.1093\/brain\/awaa269.","journal-title":"Brain"},{"key":"4388_CR9","doi-asserted-by":"publisher","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson\u2019s Disease. Cell Stem Cell. 2018;23. https:\/\/doi.org\/10.1016\/j.stem.2018.06.015. 1:123\u2009\u2013\u200931.e6.","DOI":"10.1016\/j.stem.2018.06.015"},{"key":"4388_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388 6645","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in lewy bodies. Nature. 1997;388 6645:839\u201340. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"issue":"7660","key":"4388_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 2017;546(7660):656\u201361. https:\/\/doi.org\/10.1038\/nature22815.","journal-title":"Nature"},{"key":"4388_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167 6","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson\u2019s disease. Cell. 2016;167 6:1469\u2013e8012. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","journal-title":"Cell"},{"key":"4388_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"4388_CR14","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.4049\/jimmunol.1203121","volume":"190","author":"H Gonz\u00e1lez","year":"2013","unstructured":"Gonz\u00e1lez H, Contreras F, Prado C, Elgueta D, Franz D, Bernales S, et al. Dopamine receptor D3 expressed on CD4\u2009+\u2009T cells favors neurodegeneration of dopaminergic neurons during parkinson\u2019s disease. J Immunol. 2013;190(10):5048\u201356. https:\/\/doi.org\/10.4049\/jimmunol.1203121.","journal-title":"J Immunol"},{"key":"4388_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.29369","volume":"38 5","author":"L Mu\u00f1oz-Delgado","year":"2023","unstructured":"Mu\u00f1oz-Delgado L, Labrador-Espinosa M, Mac\u00edas-Garc\u00eda D, Jes\u00fas S, Ben\u00edtez Zamora B, Fern\u00e1ndez-Rodr\u00edguez P, et al. Peripheral inflammation is associated with dopaminergic degeneration in parkinson\u2019s disease. Mov Disorders: Official J Mov Disorder Soc. 2023;38 5:755\u201363. https:\/\/doi.org\/10.1002\/mds.29369.","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"key":"4388_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","author":"VTE Aho","year":"2021","unstructured":"Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener. 2021. https:\/\/doi.org\/10.1186\/s13024-021-00427-6.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"4388_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","volume":"197","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG, McGeer PL. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp Neurol. 2006;197(2):275\u201383. https:\/\/doi.org\/10.1016\/j.expneurol.2005.10.034.","journal-title":"Exp Neurol"},{"key":"4388_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105771","volume":"170","author":"IY Abdi","year":"2022","unstructured":"Abdi IY, Ghanem SS, El-Agnaf OM. Immune-related biomarkers for Parkinson\u2019s disease. Neurobiol Dis. 2022;170: 105771. https:\/\/doi.org\/10.1016\/j.nbd.2022.105771.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4388_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli A, Camacho M, Allinson K, Williams-Gray CH. Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathol Commun. 2020;8(1): 211. https:\/\/doi.org\/10.1186\/s40478-020-01083-5.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4388_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01776-7","volume":"17","author":"J Rostami","year":"2020","unstructured":"Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergstr\u00f6m J, Essand M, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain. J Neuroinflammation. 2020;17(1): 119. https:\/\/doi.org\/10.1186\/s12974-020-01776-7.","journal-title":"J Neuroinflammation"},{"key":"4388_CR21","doi-asserted-by":"publisher","first-page":"726747","DOI":"10.3389\/fimmu.2021.726747","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Lu H, Xiong M. Identifying immune cell infiltration and effective diagnostic biomarkers in rheumatoid arthritis by bioinformatics analysis. Front Immunol. 2021;12:726747. https:\/\/doi.org\/10.3389\/fimmu.2021.726747.","journal-title":"Front Immunol"},{"key":"4388_CR22","doi-asserted-by":"publisher","first-page":"944551","DOI":"10.3389\/fphys.2022.944551","volume":"13","author":"X Lv","year":"2022","unstructured":"Lv X, Wang X, Liu J, Wang F, Sun M, Fan X, et al. Potential biomarkers and immune cell infiltration involved in aortic valve calcification identified through integrated bioinformatics analysis. Front Physiol. 2022;13:944551. https:\/\/doi.org\/10.3389\/fphys.2022.944551.","journal-title":"Front Physiol"},{"issue":"5321","key":"4388_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with parkinson\u2019s disease. Science. 1997;276(5321):2045\u20137. https:\/\/doi.org\/10.1126\/science.276.5321.2045.","journal-title":"Science"},{"key":"4388_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1083928","volume":"17","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhao L, Li H, Shen J, Li H, Xing Y. Novel diagnostic biomarkers related to immune infiltration in Parkinson\u2019s disease by bioinformatics analysis. Front Neurosci. 2023;17: 1083928. https:\/\/doi.org\/10.3389\/fnins.2023.1083928.","journal-title":"Front Neurosci"},{"key":"4388_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020175","author":"Y Bao","year":"2023","unstructured":"Bao Y, Wang L, Yu F, Yang J, Huang D. Parkinson\u2019s disease gene biomarkers screened by the LASSO and SVM algorithms. Brain Sci. 2023. https:\/\/doi.org\/10.3390\/brainsci13020175.","journal-title":"Brain Sci"},{"key":"4388_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1010361","volume":"13","author":"S Zhao","year":"2022","unstructured":"Zhao S, Zhang L, Ji W, Shi Y, Lai G, Chi H, et al. Machine learning-based characterization of cuprotosis-related biomarkers and immune infiltration in Parkinson\u2019s disease. Front Genet. 2022;13: 1010361. https:\/\/doi.org\/10.3389\/fgene.2022.1010361.","journal-title":"Front Genet"},{"issue":"1","key":"4388_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03462-y","volume":"22","author":"F Lind-Holm Mogensen","year":"2025","unstructured":"Lind-Holm Mogensen F, Seibler P, Gr\u00fcnewald A, Michelucci A. Microglial dynamics and neuroinflammation in prodromal and early Parkinson\u2019s disease. J Neuroinflammation. 2025;22(1): 136. https:\/\/doi.org\/10.1186\/s12974-025-03462-y.","journal-title":"J Neuroinflammation"},{"key":"4388_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.636139","volume":"12","author":"AF Magnusen","year":"2021","unstructured":"Magnusen AF, Hatton SL, Rani R, Pandey MK. Genetic defects and pro-inflammatory cytokines in Parkinson\u2019s disease. Front Neurol. 2021;12: 636139. https:\/\/doi.org\/10.3389\/fneur.2021.636139.","journal-title":"Front Neurol"},{"issue":"2","key":"4388_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.mehy.2014.04.029","volume":"83","author":"MA Chapman","year":"2014","unstructured":"Chapman MA. Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson\u2019s disease. Med Hypotheses. 2014;83(2):203\u20137. https:\/\/doi.org\/10.1016\/j.mehy.2014.04.029.","journal-title":"Med Hypotheses"},{"key":"4388_CR30","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1016\/j.cell.2023.07.023","volume":"186 18","author":"A Terauchi","year":"2023","unstructured":"Terauchi A, Yee P, Johnson-Venkatesh EM, Seiglie MP, Kim L, Pitino JC, et al. The projection-specific signals that Establish functionally segregated dopaminergic synapses. Cell. 2023;186 18:3845\u2013e6124. https:\/\/doi.org\/10.1016\/j.cell.2023.07.023.","journal-title":"Cell"},{"key":"4388_CR31","doi-asserted-by":"publisher","first-page":"3081891","DOI":"10.1155\/2021\/3081891","volume":"2021","author":"A Al-Rafiah","year":"2021","unstructured":"Al-Rafiah A, Magadmi R, Al-Kaabi A, Alsomali N. Parkinson\u2019s Disease-Related biomarkers that May appear in amphetamine abusers. Biomed Res Int. 2021;2021:3081891. https:\/\/doi.org\/10.1155\/2021\/3081891.","journal-title":"Biomed Res Int"},{"key":"4388_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainresbull.2021.09.010","volume":"177","author":"X Chen","year":"2021","unstructured":"Chen X, Cao W, Zhuang Y, Chen S, Li X. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson\u2019s disease. Brain Res Bull. 2021;177:53\u201363. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.09.010.","journal-title":"Brain Res Bull"},{"issue":"4","key":"4388_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1755-5949.2008.00058.x","volume":"14","author":"M Hadjiconstantinou","year":"2008","unstructured":"Hadjiconstantinou M, Neff NH. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in parkinson\u2019s disease. CNS Neurosci Ther. 2008;14(4):340\u201351. https:\/\/doi.org\/10.1111\/j.1755-5949.2008.00058.x.","journal-title":"CNS Neurosci Ther"},{"key":"4388_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02706-0","author":"J Rutledge","year":"2024","unstructured":"Rutledge J, Lehallier B, Zarifkar P, Losada PM, Shahid-Besanti M, Western D, et al. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol. 2024. https:\/\/doi.org\/10.1007\/s00401-024-02706-0.","journal-title":"Acta Neuropathol"},{"key":"4388_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2017.09.054","volume":"661","author":"NJ Rutherford","year":"2017","unstructured":"Rutherford NJ, Brooks M, Riffe CJ, Gorion KM, Howard JK, Dhillon JS, et al. Prion-like transmission of \u03b1-synuclein pathology in the context of an NFL null background. Neurosci Lett. 2017;661:114\u201320. https:\/\/doi.org\/10.1016\/j.neulet.2017.09.054.","journal-title":"Neurosci Lett"},{"key":"4388_CR36","doi-asserted-by":"publisher","unstructured":"Zucchi E, Bonetto V, Sorar\u00f9 G, Martinelli I, Parchi P, Liguori R, et al. Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegeneration. 2020;15(1:58). https:\/\/doi.org\/10.1186\/s13024-020-00406-3.","DOI":"10.1186\/s13024-020-00406-3"},{"key":"4388_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107851","volume":"135","author":"X Jiao","year":"2025","unstructured":"Jiao X, Lu Y, Huang Y, Chen J, Gu Z, Gao X, et al. Plasma proteomic profiling reveals Parkinson\u2019s disease-associated proteins: a UK biobank study. Parkinsonism Relat Disord. 2025;135: 107851. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107851.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"4388_CR38","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1586\/14737175.2014.960399","volume":"14","author":"KM Lohr","year":"2014","unstructured":"Lohr KM, Miller GW. VMAT2 and Parkinson\u2019s disease: harnessing the dopamine vesicle. Expert Rev Neurother. 2014;14(10):1115\u20137. https:\/\/doi.org\/10.1586\/14737175.2014.960399.","journal-title":"Expert Rev Neurother"},{"key":"4388_CR39","doi-asserted-by":"publisher","first-page":"903164","DOI":"10.1155\/2015\/903164","volume":"2015","author":"X Yang","year":"2015","unstructured":"Yang X, Xu P, Zhao Q, An R, Jia H, Liu Z, et al. Polymorphism in the vesicular monoamine transporter 2 gene decreases the risk of parkinson\u2019s disease in Han Chinese men. Parkinson\u2019s Disease. 2015;2015:903164. https:\/\/doi.org\/10.1155\/2015\/903164.","journal-title":"Parkinson\u2019s Disease"},{"key":"4388_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03565-8","author":"H Zhang","year":"2023","unstructured":"Zhang H, Nagai J, Hao L, Jiang X. Identification of key genes and immunological features associated with copper metabolism in Parkinson\u2019s disease by bioinformatics analysis. Mol Neurobiol. 2023. https:\/\/doi.org\/10.1007\/s12035-023-03565-8.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"4388_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0891988721996802","volume":"35","author":"JT Hinkle","year":"2022","unstructured":"Hinkle JT, Mills KA, Perepezko K, Pontone GM. Bidirectional correlations between dopaminergic function and motivation in Parkinson\u2019s disease. J Geriatr Psychiatr Neurol. 2022;35(3):353\u201362. https:\/\/doi.org\/10.1177\/0891988721996802.","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"4388_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67 12","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2008;67 12:1149\u201358. https:\/\/doi.org\/10.1097\/NEN.0b013e31818e5e99.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"4388_CR43","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain. 2021;144(7):2047\u201359. https:\/\/doi.org\/10.1093\/brain\/awab103.","journal-title":"Brain"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04388-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04388-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04388-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T01:32:28Z","timestamp":1756258348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04388-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4388"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04388-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants received approval from the Board of Directors and the Ethics Committee of Lishui City People\u2019s Hospital (approval number LCPH20240047) and were carried out in compliance with the 1975 Declaration of Helsinki. Informed written consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}